Using DealForma insights, PharmaShots’ Top 20 Biopharma Deal Terminations of 2024 highlights major partnership cancellations, led by the $4.45B Adaptimmune–Genentech deal. Read it here
Using DealForma insights, PharmaShots’ Top 20 Biopharma Deal Terminations of 2024 highlights major partnership cancellations, led by the $4.45B Adaptimmune–Genentech deal. Read it here
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
